Optical delineation of human malignant melanoma using second harmonic imaging of collagen

Skin cancer incidence has increased exponentially over the last three decades. In 2008 skin cancer caused 2280 deaths in the UK, with 2067 due to malignant melanoma. Early diagnosis can prevent mortality, however, conventional treatment requires multiple procedures and increasing treatment times. Se...

Full description

Saved in:
Bibliographic Details
Published inBiomedical optics express Vol. 2; no. 5; pp. 1282 - 1295
Main Authors Thrasivoulou, C., Virich, G., Krenacs, T., Korom, I., Becker, D. L.
Format Journal Article
LanguageEnglish
Published United States Optical Society of America 01.05.2011
Subjects
Online AccessGet full text
ISSN2156-7085
2156-7085
DOI10.1364/BOE.2.001282

Cover

Abstract Skin cancer incidence has increased exponentially over the last three decades. In 2008 skin cancer caused 2280 deaths in the UK, with 2067 due to malignant melanoma. Early diagnosis can prevent mortality, however, conventional treatment requires multiple procedures and increasing treatment times. Second harmonic generation (SHG) imaging could offer diagnosis and demarcation of melanoma borders non-invasively at presentation thereby short-cutting the excision biopsy stage. To test the efficacy and accuracy of SHG imaging of collagen in skin and to delineate the borders of skin cancers, unstained human melanoma biopsy sections were imaged using SHG microscopy. Comparisons with sister sections, stained with H&E or Melan-A were made for correlation of invasion borders. Fresh ex vivo normal human and rat skin was imaged through its whole thickness using SHG to demonstrate this technique is transferable to in vivo tissues. SHG imaging demonstrated detailed collagen distribution in normal skin, with total absence of SHG signal (fibrillar collagen) within the melanoma-invaded tissue. The presence or absence of signal changes dramatically at the borders of the melanoma, accurately demarcating the edges that strongly correlated with H&E and Melan-A defined borders (p<0.002). SHG imaging of ex vivo human and rat skin demonstrated collagen architecture could be imaged through the full thickness of the skin. We propose that SHG imaging could be used for diagnosis and accurate demarcation of melanoma borders on presentation and therefore potentially reduce mortality rates.
AbstractList Skin cancer incidence has increased exponentially over the last three decades. In 2008 skin cancer caused 2280 deaths in the UK, with 2067 due to malignant melanoma. Early diagnosis can prevent mortality, however, conventional treatment requires multiple procedures and increasing treatment times. Second harmonic generation (SHG) imaging could offer diagnosis and demarcation of melanoma borders non-invasively at presentation thereby short-cutting the excision biopsy stage. To test the efficacy and accuracy of SHG imaging of collagen in skin and to delineate the borders of skin cancers, unstained human melanoma biopsy sections were imaged using SHG microscopy. Comparisons with sister sections, stained with H&E or Melan-A were made for correlation of invasion borders. Fresh ex vivo normal human and rat skin was imaged through its whole thickness using SHG to demonstrate this technique is transferable to in vivo tissues. SHG imaging demonstrated detailed collagen distribution in normal skin, with total absence of SHG signal (fibrillar collagen) within the melanoma-invaded tissue. The presence or absence of signal changes dramatically at the borders of the melanoma, accurately demarcating the edges that strongly correlated with H&E and Melan-A defined borders ( p <0.002). SHG imaging of ex vivo human and rat skin demonstrated collagen architecture could be imaged through the full thickness of the skin. We propose that SHG imaging could be used for diagnosis and accurate demarcation of melanoma borders on presentation and therefore potentially reduce mortality rates.
Skin cancer incidence has increased exponentially over the last three decades. In 2008 skin cancer caused 2280 deaths in the UK, with 2067 due to malignant melanoma. Early diagnosis can prevent mortality, however, conventional treatment requires multiple procedures and increasing treatment times. Second harmonic generation (SHG) imaging could offer diagnosis and demarcation of melanoma borders non-invasively at presentation thereby short-cutting the excision biopsy stage. To test the efficacy and accuracy of SHG imaging of collagen in skin and to delineate the borders of skin cancers, unstained human melanoma biopsy sections were imaged using SHG microscopy. Comparisons with sister sections, stained with H&E or Melan-A were made for correlation of invasion borders. Fresh ex vivo normal human and rat skin was imaged through its whole thickness using SHG to demonstrate this technique is transferable to in vivo tissues. SHG imaging demonstrated detailed collagen distribution in normal skin, with total absence of SHG signal (fibrillar collagen) within the melanoma-invaded tissue. The presence or absence of signal changes dramatically at the borders of the melanoma, accurately demarcating the edges that strongly correlated with H&E and Melan-A defined borders (p<0.002). SHG imaging of ex vivo human and rat skin demonstrated collagen architecture could be imaged through the full thickness of the skin. We propose that SHG imaging could be used for diagnosis and accurate demarcation of melanoma borders on presentation and therefore potentially reduce mortality rates.
Skin cancer incidence has increased exponentially over the last three decades. In 2008 skin cancer caused 2280 deaths in the UK, with 2067 due to malignant melanoma. Early diagnosis can prevent mortality, however, conventional treatment requires multiple procedures and increasing treatment times. Second harmonic generation (SHG) imaging could offer diagnosis and demarcation of melanoma borders non-invasively at presentation thereby short-cutting the excision biopsy stage. To test the efficacy and accuracy of SHG imaging of collagen in skin and to delineate the borders of skin cancers, unstained human melanoma biopsy sections were imaged using SHG microscopy. Comparisons with sister sections, stained with H&E or Melan-A were made for correlation of invasion borders. Fresh ex vivo normal human and rat skin was imaged through its whole thickness using SHG to demonstrate this technique is transferable to in vivo tissues. SHG imaging demonstrated detailed collagen distribution in normal skin, with total absence of SHG signal (fibrillar collagen) within the melanoma-invaded tissue. The presence or absence of signal changes dramatically at the borders of the melanoma, accurately demarcating the edges that strongly correlated with H&E and Melan-A defined borders (p<0.002). SHG imaging of ex vivo human and rat skin demonstrated collagen architecture could be imaged through the full thickness of the skin. We propose that SHG imaging could be used for diagnosis and accurate demarcation of melanoma borders on presentation and therefore potentially reduce mortality rates.Skin cancer incidence has increased exponentially over the last three decades. In 2008 skin cancer caused 2280 deaths in the UK, with 2067 due to malignant melanoma. Early diagnosis can prevent mortality, however, conventional treatment requires multiple procedures and increasing treatment times. Second harmonic generation (SHG) imaging could offer diagnosis and demarcation of melanoma borders non-invasively at presentation thereby short-cutting the excision biopsy stage. To test the efficacy and accuracy of SHG imaging of collagen in skin and to delineate the borders of skin cancers, unstained human melanoma biopsy sections were imaged using SHG microscopy. Comparisons with sister sections, stained with H&E or Melan-A were made for correlation of invasion borders. Fresh ex vivo normal human and rat skin was imaged through its whole thickness using SHG to demonstrate this technique is transferable to in vivo tissues. SHG imaging demonstrated detailed collagen distribution in normal skin, with total absence of SHG signal (fibrillar collagen) within the melanoma-invaded tissue. The presence or absence of signal changes dramatically at the borders of the melanoma, accurately demarcating the edges that strongly correlated with H&E and Melan-A defined borders (p<0.002). SHG imaging of ex vivo human and rat skin demonstrated collagen architecture could be imaged through the full thickness of the skin. We propose that SHG imaging could be used for diagnosis and accurate demarcation of melanoma borders on presentation and therefore potentially reduce mortality rates.
Author Krenacs, T.
Becker, D. L.
Virich, G.
Thrasivoulou, C.
Korom, I.
Author_xml – sequence: 1
  givenname: C.
  surname: Thrasivoulou
  fullname: Thrasivoulou, C.
– sequence: 2
  givenname: G.
  surname: Virich
  fullname: Virich, G.
– sequence: 3
  givenname: T.
  surname: Krenacs
  fullname: Krenacs, T.
– sequence: 4
  givenname: I.
  surname: Korom
  fullname: Korom, I.
– sequence: 5
  givenname: D. L.
  surname: Becker
  fullname: Becker, D. L.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21559140$$D View this record in MEDLINE/PubMed
BookMark eNptUTtPwzAQthCIlsfGjLyx0OJXEmdBAsRLqtQFBibLdS6pkWOXOEHi32NoQYDwcpbve_ju20PbPnhA6IiSKeW5OLucX0_ZlBDKJNtCY0azfFIQmW3_uI_QYYzPJB0hCsLlLhqlXlZSQcboab7qrdEOV-CsB93b4HGo8XJotcetdrbx2ve4Bad9aDUeovUNjmCCr_BSd23w1mDb6ubjPTFNcE434A_QTq1dhMNN3UePN9cPV3eT2fz2_upiNjFc8n5iSgbGCEO5Zjov-AJ4VWnIgNVMkAUpOKcgBV9UZVYXoigryQitqOCmrEVu-D46X-uuhkULlQHfd9qpVZf-1L2poK363fF2qZrwqjiRRSazJHCyEejCywCxV62NBtIUHsIQlcxzJkrBSEIe_7T69vhaZwKwNcB0IcYOamVs_7nT5GydokR9xKZSbIqpdWyJdPqH9KX7L_wdpnaZtg
CitedBy_id crossref_primary_10_3390_healthcare1010064
crossref_primary_10_1038_srep08879
crossref_primary_10_1002_jbio_201200059
crossref_primary_10_1038_s41598_022_25055_y
crossref_primary_10_1364_BOE_3_002021
crossref_primary_10_1186_s42047_021_00089_0
crossref_primary_10_1364_BOE_5_001355
crossref_primary_10_1364_BOE_10_000514
crossref_primary_10_1364_BOE_505220
crossref_primary_10_1111_iwj_12789
crossref_primary_10_1117_1_JBO_17_6_066004
crossref_primary_10_1364_BOE_7_004480
crossref_primary_10_5005_jp_journals_10015_1442
crossref_primary_10_17650_1726_9776_2017_13_4_101_106
crossref_primary_10_1364_OSAC_425373
crossref_primary_10_1016_j_md_2015_11_002
crossref_primary_10_1117_1_BIOS_1_1_015004
crossref_primary_10_1007_s12127_013_0124_6
crossref_primary_10_1098_rsif_2013_0263
crossref_primary_10_3390_life14020231
crossref_primary_10_1002_jbio_201300176
crossref_primary_10_1016_j_biomaterials_2018_08_039
crossref_primary_10_1364_OE_20_021821
Cites_doi 10.1023/B:CLIN.0000006824.41376.b0
10.1364/OL.28.002488
10.1016/j.gde.2009.10.011
10.1038/nm879
10.1063/1.437677
10.1007/s10585-008-9204-0
10.1007/s00403-001-0289-4
10.1016/0923-1811(95)00470-X
10.1016/j.sder.2009.06.007
10.1007/s10198-008-0127-0
10.1364/AO.10.002350
10.1529/biophysj.106.093740
10.1111/j.0022-202X.2004.23569.x
10.1111/j.1524-4725.2006.32053.x
10.1054/bjoc.1999.0978
10.1109/JQE.1977.1069615
10.1016/S1047-8477(02)00576-2
10.1136/gut.52.suppl_4.iv1
10.1117/1.2983664
10.4065/81.4.500
10.3322/canjclin.55.2.74
10.1158/1078-0432.CCR-05-2559
10.1001/archfaci.7.4.238
10.1007/s10555-005-1572-1
10.3322/caac.20074
10.1007/s00403-003-0429-0
10.1097/01.cmr.0000195700.42766.23
10.1117/1.1383294
10.1529/biophysj.104.047308
ContentType Journal Article
Copyright 2011 Optical Society of America 2011 OSA
Copyright_xml – notice: 2011 Optical Society of America 2011 OSA
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.1364/BOE.2.001282
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Engineering
EISSN 2156-7085
EndPage 1295
ExternalDocumentID PMC3087585
21559140
10_1364_BOE_2_001282
Genre Journal Article
GrantInformation_xml – fundername: UCL Business
GroupedDBID 4.4
53G
8SL
AAFWJ
AAWJZ
AAYXX
ADBBV
AEDJG
AENEX
AFPKN
AKGWG
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ATHME
AYPRP
AZSQR
AZYMN
BAWUL
BCNDV
CITATION
DIK
DSZJF
E3Z
EBS
EJD
GROUPED_DOAJ
GX1
HYE
KQ8
LPK
M~E
O5R
O5S
OFLFD
OK1
OPJBK
ROL
ROS
RPM
TR6
NPM
7X8
5PM
ID FETCH-LOGICAL-c383t-c92ecc4c13a2a673be3ddae5e2f240b07331e843bd95f7479d8201d143c9f46c3
ISSN 2156-7085
IngestDate Thu Aug 21 18:18:19 EDT 2025
Fri Jul 11 00:58:21 EDT 2025
Mon Jul 21 05:54:34 EDT 2025
Tue Jul 01 02:13:40 EDT 2025
Thu Apr 24 22:52:11 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords (170.3880) Medical and biological imaging
(180.4315) Nonlinear microscopy
(180.1790) Confocal microscopy
(190.1900) Diagnostic applications of nonlinear optics
Language English
License https://opg.optica.org/policies/opg-tdm-policy.json
https://doi.org/10.1364/OA_License_v1#VOR-OA
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License, which permits download and redistribution, provided that the original work is properly cited. This license restricts the article from being modified or used commercially.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c383t-c92ecc4c13a2a673be3ddae5e2f240b07331e843bd95f7479d8201d143c9f46c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://dx.doi.org/10.1364/BOE.2.001282
PMID 21559140
PQID 866249420
PQPubID 23479
PageCount 14
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3087585
proquest_miscellaneous_866249420
pubmed_primary_21559140
crossref_citationtrail_10_1364_BOE_2_001282
crossref_primary_10_1364_BOE_2_001282
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-05-01
PublicationDateYYYYMMDD 2011-05-01
PublicationDate_xml – month: 05
  year: 2011
  text: 2011-05-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Biomedical optics express
PublicationTitleAlternate Biomed Opt Express
PublicationYear 2011
Publisher Optical Society of America
Publisher_xml – name: Optical Society of America
References Roth (boe-2-5-1282-R16) 1979; 70
Hompland (boe-2-5-1282-R30) 2008; 13
Lien (boe-2-5-1282-R12) 2009; 144
Theodossiou (boe-2-5-1282-R14) 2006; 91
Brown (boe-2-5-1282-R22) 2003; 9
Campagnola (boe-2-5-1282-R20) 2001; 6
Sun (boe-2-5-1282-R23) 2003; 28
Wach (boe-2-5-1282-R7) 1996; 12
Wandel (boe-2-5-1282-R8) 2002; 293
Monhian (boe-2-5-1282-R4) 2005; 7
Ntayi (boe-2-5-1282-R5) 2003; 295
Varani (boe-2-5-1282-R6) 2000; 82
Lohela (boe-2-5-1282-R10) 2010; 20
Eves (boe-2-5-1282-R3) 2003; 20
Kuphal (boe-2-5-1282-R26) 2005; 24
Paoli (boe-2-5-1282-R11) 2009; 28
Gerger (boe-2-5-1282-R18) 2005; 124
Cox (boe-2-5-1282-R19) 2003; 141
Cummins (boe-2-5-1282-R24) 2006; 81
Rigel (boe-2-5-1282-R29) 2010; 60
Williams (boe-2-5-1282-R21) 2005; 88
Weinstock (boe-2-5-1282-R25) 2006; 12
Morris (boe-2-5-1282-R1) 2009; 10
Scoazec (boe-2-5-1282-R9) 2003; 52
Fikrle (boe-2-5-1282-R28) 2006; 16
Sheppard (boe-2-5-1282-R15) 1977; 13
de Giorgi (boe-2-5-1282-R27) 2006; 32
Parkin (boe-2-5-1282-R2) 2005; 55
Provenzano (boe-2-5-1282-R17) 2009; 26
Fine (boe-2-5-1282-R13) 1971; 10
16432455 - Melanoma Res. 2006 Feb;16(1):45-50
16027344 - Arch Facial Plast Surg. 2005 Jul-Aug;7(4):238-43
16610570 - Mayo Clin Proc. 2006 Apr;81(4):500-7
14530987 - Arch Dermatol Res. 2003 Nov;295(6):236-41
17130233 - Biophys J. 2006 Dec 15;91(12):4665-77
14713103 - Clin Exp Metastasis. 2003;20(8):685-700
19942428 - Curr Opin Genet Dev. 2010 Feb;20(1):72-8
15533922 - Biophys J. 2005 Feb;88(2):1377-86
12746261 - Gut. 2003 Jun;52 Suppl 4:iv1-6
19357625 - G Ital Dermatol Venereol. 2009 Apr;144(2):187-94
20111328 - Appl Opt. 1971 Oct 1;10(10):2350-3
12576020 - J Struct Biol. 2003 Jan;141(1):53-62
16442056 - Dermatol Surg. 2006 Feb;32(2):282-6
10682680 - Br J Cancer. 2000 Feb;82(3):657-65
14690123 - Opt Lett. 2003 Dec 15;28(24):2488-90
18791757 - Eur J Health Econ. 2009 Jul;10(3):267-73
15761078 - CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
8814543 - J Dermatol Sci. 1996 Jun;12(2):118-26
11875642 - Arch Dermatol Res. 2002 Feb;293(12):601-8
20671054 - CA Cancer J Clin. 2010 Sep-Oct;60(5):301-16
12754503 - Nat Med. 2003 Jun;9(6):796-800
19782943 - Semin Cutan Med Surg. 2009 Sep;28(3):190-5
11516317 - J Biomed Opt. 2001 Jul;6(3):277-86
16609048 - Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2297s-2300s
15737188 - J Invest Dermatol. 2005 Mar;124(3):493-8
18766302 - Clin Exp Metastasis. 2009;26(4):357-70
15986132 - Cancer Metastasis Rev. 2005 Jun;24(2):195-222
19021430 - J Biomed Opt. 2008 Sep-Oct;13(5):054050
References_xml – volume: 20
  start-page: 685
  year: 2003
  ident: boe-2-5-1282-R3
  publication-title: Clin. Exp. Metastasis
  doi: 10.1023/B:CLIN.0000006824.41376.b0
– volume: 28
  start-page: 2488
  year: 2003
  ident: boe-2-5-1282-R23
  publication-title: Opt. Lett.
  doi: 10.1364/OL.28.002488
– volume: 20
  start-page: 72
  year: 2010
  ident: boe-2-5-1282-R10
  publication-title: Curr. Opin. Genet. Dev.
  doi: 10.1016/j.gde.2009.10.011
– volume: 9
  start-page: 796
  year: 2003
  ident: boe-2-5-1282-R22
  publication-title: Nat. Med.
  doi: 10.1038/nm879
– volume: 70
  start-page: 1637
  year: 1979
  ident: boe-2-5-1282-R16
  publication-title: J. Chem. Phys.
  doi: 10.1063/1.437677
– volume: 26
  start-page: 357
  year: 2009
  ident: boe-2-5-1282-R17
  publication-title: Clin. Exp. Metastasis
  doi: 10.1007/s10585-008-9204-0
– volume: 293
  start-page: 601
  year: 2002
  ident: boe-2-5-1282-R8
  publication-title: Arch. Dermatol. Res.
  doi: 10.1007/s00403-001-0289-4
– volume: 12
  start-page: 118
  year: 1996
  ident: boe-2-5-1282-R7
  publication-title: J. Dermatol. Sci.
  doi: 10.1016/0923-1811(95)00470-X
– volume: 28
  start-page: 190
  year: 2009
  ident: boe-2-5-1282-R11
  publication-title: Semin. Cutan. Med. Surg.
  doi: 10.1016/j.sder.2009.06.007
– volume: 144
  start-page: 187
  year: 2009
  ident: boe-2-5-1282-R12
  publication-title: G. Ital. Dermatol. Venereol.
– volume: 10
  start-page: 267
  year: 2009
  ident: boe-2-5-1282-R1
  publication-title: Eur. J. Health Econ.
  doi: 10.1007/s10198-008-0127-0
– volume: 10
  start-page: 2350
  year: 1971
  ident: boe-2-5-1282-R13
  publication-title: Appl. Opt.
  doi: 10.1364/AO.10.002350
– volume: 91
  start-page: 4665
  year: 2006
  ident: boe-2-5-1282-R14
  publication-title: Biophys. J.
  doi: 10.1529/biophysj.106.093740
– volume: 124
  start-page: 493
  year: 2005
  ident: boe-2-5-1282-R18
  publication-title: J. Invest. Dermatol.
  doi: 10.1111/j.0022-202X.2004.23569.x
– volume: 32
  start-page: 282
  year: 2006
  ident: boe-2-5-1282-R27
  publication-title: Dermatol. Surg.
  doi: 10.1111/j.1524-4725.2006.32053.x
– volume: 82
  start-page: 657
  year: 2000
  ident: boe-2-5-1282-R6
  publication-title: Br. J. Cancer
  doi: 10.1054/bjoc.1999.0978
– volume: 13
  start-page: 912
  year: 1977
  ident: boe-2-5-1282-R15
  publication-title: IEEE J. Quantum Electron.
  doi: 10.1109/JQE.1977.1069615
– volume: 141
  start-page: 53
  year: 2003
  ident: boe-2-5-1282-R19
  publication-title: J. Struct. Biol.
  doi: 10.1016/S1047-8477(02)00576-2
– volume: 52
  start-page: 1i
  year: 2003
  ident: boe-2-5-1282-R9
  publication-title: Gut
  doi: 10.1136/gut.52.suppl_4.iv1
– volume: 13
  start-page: 054050
  year: 2008
  ident: boe-2-5-1282-R30
  publication-title: J. Biomed. Opt.
  doi: 10.1117/1.2983664
– volume: 81
  start-page: 500
  year: 2006
  ident: boe-2-5-1282-R24
  publication-title: Mayo Clin. Proc.
  doi: 10.4065/81.4.500
– volume: 55
  start-page: 74
  year: 2005
  ident: boe-2-5-1282-R2
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/canjclin.55.2.74
– volume: 12
  start-page: 2297s
  year: 2006
  ident: boe-2-5-1282-R25
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-05-2559
– volume: 7
  start-page: 238
  year: 2005
  ident: boe-2-5-1282-R4
  publication-title: Arch. Facial Plast. Surg.
  doi: 10.1001/archfaci.7.4.238
– volume: 24
  start-page: 195
  year: 2005
  ident: boe-2-5-1282-R26
  publication-title: Cancer Metastasis Rev.
  doi: 10.1007/s10555-005-1572-1
– volume: 60
  start-page: 301
  year: 2010
  ident: boe-2-5-1282-R29
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.20074
– volume: 295
  start-page: 236
  year: 2003
  ident: boe-2-5-1282-R5
  publication-title: Arch. Dermatol. Res.
  doi: 10.1007/s00403-003-0429-0
– volume: 16
  start-page: 45
  year: 2006
  ident: boe-2-5-1282-R28
  publication-title: Melanoma Res.
  doi: 10.1097/01.cmr.0000195700.42766.23
– volume: 6
  start-page: 277
  year: 2001
  ident: boe-2-5-1282-R20
  publication-title: J. Biomed. Opt.
  doi: 10.1117/1.1383294
– volume: 88
  start-page: 1377
  year: 2005
  ident: boe-2-5-1282-R21
  publication-title: Biophys. J.
  doi: 10.1529/biophysj.104.047308
– reference: 15533922 - Biophys J. 2005 Feb;88(2):1377-86
– reference: 16610570 - Mayo Clin Proc. 2006 Apr;81(4):500-7
– reference: 11875642 - Arch Dermatol Res. 2002 Feb;293(12):601-8
– reference: 20671054 - CA Cancer J Clin. 2010 Sep-Oct;60(5):301-16
– reference: 12576020 - J Struct Biol. 2003 Jan;141(1):53-62
– reference: 18766302 - Clin Exp Metastasis. 2009;26(4):357-70
– reference: 11516317 - J Biomed Opt. 2001 Jul;6(3):277-86
– reference: 15761078 - CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
– reference: 16432455 - Melanoma Res. 2006 Feb;16(1):45-50
– reference: 19782943 - Semin Cutan Med Surg. 2009 Sep;28(3):190-5
– reference: 16442056 - Dermatol Surg. 2006 Feb;32(2):282-6
– reference: 15737188 - J Invest Dermatol. 2005 Mar;124(3):493-8
– reference: 12754503 - Nat Med. 2003 Jun;9(6):796-800
– reference: 14530987 - Arch Dermatol Res. 2003 Nov;295(6):236-41
– reference: 19021430 - J Biomed Opt. 2008 Sep-Oct;13(5):054050
– reference: 16027344 - Arch Facial Plast Surg. 2005 Jul-Aug;7(4):238-43
– reference: 14690123 - Opt Lett. 2003 Dec 15;28(24):2488-90
– reference: 12746261 - Gut. 2003 Jun;52 Suppl 4:iv1-6
– reference: 16609048 - Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2297s-2300s
– reference: 19942428 - Curr Opin Genet Dev. 2010 Feb;20(1):72-8
– reference: 20111328 - Appl Opt. 1971 Oct 1;10(10):2350-3
– reference: 14713103 - Clin Exp Metastasis. 2003;20(8):685-700
– reference: 17130233 - Biophys J. 2006 Dec 15;91(12):4665-77
– reference: 8814543 - J Dermatol Sci. 1996 Jun;12(2):118-26
– reference: 19357625 - G Ital Dermatol Venereol. 2009 Apr;144(2):187-94
– reference: 18791757 - Eur J Health Econ. 2009 Jul;10(3):267-73
– reference: 10682680 - Br J Cancer. 2000 Feb;82(3):657-65
– reference: 15986132 - Cancer Metastasis Rev. 2005 Jun;24(2):195-222
SSID ssj0000447038
Score 2.072337
Snippet Skin cancer incidence has increased exponentially over the last three decades. In 2008 skin cancer caused 2280 deaths in the UK, with 2067 due to malignant...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1282
SubjectTerms Optics in Cancer Research
Title Optical delineation of human malignant melanoma using second harmonic imaging of collagen
URI https://www.ncbi.nlm.nih.gov/pubmed/21559140
https://www.proquest.com/docview/866249420
https://pubmed.ncbi.nlm.nih.gov/PMC3087585
Volume 2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZgkRAcECyv8lj5AKcqpXUcJz4itLCAlr3sonKK7NhZKrVJ1TYI8esZT-w0XYq0cIkqvxJ1Po_H8yTklebMCFPEkS6tiTjTJpJwskQ6dVa4VCqF6ZpOv4iTC_5pmky3FnyMLtnoUfFrb1zJ_1AV2oCuLkr2HyjbLQoN8BvoC0-gMDyvReOzZauJNi6ovCf8oWJ-ARL2pXNzGS7sXFX1Qg0bVAys3R3YDF3Oaix_M1v4SkXOwRxQcemjw4KpFwP08T31EpM625_LznEDfUpWaj37UTfzukG96yj0fJ0Bl0W9zYeu7fPKVso7J20b61WNwPw46qshnF41OP213AoILKJ03NbfGdk9bZ7dsh6qkh7rhIOS7eXpseDOU_3seORyq4Zhu6mzrxxpnaMh2usEz2F2zvJ29k1yi6UgaLnI8OmkU8iNOQfuhxUMw2f7QAlY4E3_9bsizB_3kqvutT155fw-uecvGvRti5oH5IatDsndXvrJQ3L71DtWPCTfPJRoD0q0LilCiXZQogFKFKFEWyjRACXqoeRmBig9Ihfvj8_fnUS-6kZUxFm8iQrJYFvzYhIrpkQaaxsbo2xiWQnSn8YinzbjsTYyKeEyKo0TIg3I3YUsuSjix-Sgqiv7lFDY51lWGlumOuU8w2SQE6EYTwopeSEHZBj-yLzwKeldZZR5vo9uA_K6G71sU7H8ZRwNNMmBVzoDmKps3azzTAjGJWfjAXnSkqhbiDnz_IRDT7pDvG6AS8O-21PNvmM6dpdTEy7dz675ec_Jne3-eUEONqvGvgTBdqOPUCF0hLD8DaRrpBQ
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Optical+delineation+of+human+malignant+melanoma+using+second+harmonic+imaging+of+collagen&rft.jtitle=Biomedical+optics+express&rft.au=Thrasivoulou%2C+C.&rft.au=Virich%2C+G.&rft.au=Krenacs%2C+T.&rft.au=Korom%2C+I.&rft.date=2011-05-01&rft.issn=2156-7085&rft.eissn=2156-7085&rft.volume=2&rft.issue=5&rft.spage=1282&rft_id=info:doi/10.1364%2FBOE.2.001282&rft.externalDBID=n%2Fa&rft.externalDocID=10_1364_BOE_2_001282
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2156-7085&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2156-7085&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2156-7085&client=summon